BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32215174)

  • 1. miR-155-5p Promotes Oxalate- and Calcium-Induced Kidney Oxidative Stress Injury by Suppressing MGP Expression.
    Jiang K; Hu J; Luo G; Song D; Zhang P; Zhu J; Sun F
    Oxid Med Cell Longev; 2020; 2020():5863617. PubMed ID: 32215174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theaflavin protects against oxalate calcium-induced kidney oxidative stress injury via upregulation of SIRT1.
    Ye T; Yang X; Liu H; Lv P; Lu H; Jiang K; Peng E; Ye Z; Chen Z; Tang K
    Int J Biol Sci; 2021; 17(4):1050-1060. PubMed ID: 33867828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium oxalate nephrolithiasis and expression of matrix GLA protein in the kidneys.
    Khan A; Wang W; Khan SR
    World J Urol; 2014 Feb; 32(1):123-30. PubMed ID: 23475213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature Senescence and Telomere Shortening Induced by Oxidative Stress From Oxalate, Calcium Oxalate Monohydrate, and Urine From Patients With Calcium Oxalate Nephrolithiasis.
    Chuenwisad K; More-Krong P; Tubsaeng P; Chotechuang N; Srisa-Art M; Storer RJ; Boonla C
    Front Immunol; 2021; 12():696486. PubMed ID: 34745087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HOXA11-AS regulates calcium oxalate crystal-induced renal inflammation via miR-124-3p/MCP-1.
    Li Y; Yan G; Zhang J; Chen W; Ding T; Yin Y; Li M; Zhu Y; Sun S; Yuan JH; Guo Z
    J Cell Mol Med; 2020 Jan; 24(1):238-249. PubMed ID: 31680444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA-ATB participates in the regulation of calcium oxalate crystal-induced renal injury by sponging the miR-200 family.
    Li Y; Ding T; Hu H; Zhao T; Zhu C; Ding J; Yuan J; Guo Z
    Mol Med; 2021 Nov; 27(1):143. PubMed ID: 34736391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tea polyphenol protects against HK-2 cell injury induced by oxalate and calcium oxalate monohydrate crystals].
    Wang S; Huang XB; Xu QQ; Ye HY; Ma K; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):567-74. PubMed ID: 23939164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-21 promotes calcium oxalate-induced renal tubular cell injury by targeting PPARA.
    Su B; Han H; Ji C; Hu W; Yao J; Yang J; Fan Y; Li J
    Am J Physiol Renal Physiol; 2020 Aug; 319(2):F202-F214. PubMed ID: 32628541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H19 promote calcium oxalate nephrocalcinosis-induced renal tubular epithelial cell injury via a ceRNA pathway.
    Liu H; Ye T; Yang X; Liu J; Jiang K; Lu H; Xia D; Peng E; Chen Z; Sun F; Tang K; Ye Z
    EBioMedicine; 2019 Dec; 50():366-378. PubMed ID: 31735555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-204 attenuates oxidative stress damage of renal tubular epithelial cells in calcium oxalate kidney-stone formation via MUC4-mediated ERK signaling pathway.
    Xie Z; Chen J; Chen Z
    Urolithiasis; 2022 Feb; 50(1):1-10. PubMed ID: 34783868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuin1 inhibits calcium oxalate crystal-induced kidney injury by regulating TLR4 signaling and macrophage-mediated inflammatory activation.
    Duan C; Liu H; Yang X; Liu J; Deng Y; Wang T; Xing J; Hu Z; Xu H
    Cell Signal; 2023 Dec; 112():110887. PubMed ID: 37717713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis.
    Liu H; Yang X; Tang K; Ye T; Duan C; Lv P; Yan L; Wu X; Chen Z; Liu J; Deng Y; Zeng G; Xing J; Ye Z; Xu H
    Theranostics; 2020; 10(16):7319-7334. PubMed ID: 32641994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of miRNA-141-3p in Calcium Oxalate-Induced Renal Tubular Epithelial Cell Injury via NLRP3-Mediated Pyroptosis.
    Gan XG; Wang ZH; Xu HT
    Kidney Blood Press Res; 2022; 47(5):300-308. PubMed ID: 35081536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XIST Inhibition Attenuates Calcium Oxalate Nephrocalcinosis-Induced Renal Inflammation and Oxidative Injury via the miR-223/NLRP3 Pathway.
    Lv P; Liu H; Ye T; Yang X; Duan C; Yao X; Li B; Tang K; Chen Z; Liu J; Deng Y; Wang T; Xing J; Liang C; Xu H; Ye Z
    Oxid Med Cell Longev; 2021; 2021():1676152. PubMed ID: 34512861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA LINC00339 promotes renal tubular epithelial pyroptosis by regulating the miR-22-3p/NLRP3 axis in calcium oxalate-induced kidney stone.
    Song Z; Zhang Y; Gong B; Xu H; Hao Z; Liang C
    J Cell Biochem; 2019 Jun; 120(6):10452-10462. PubMed ID: 30614043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaempferol alleviates calcium oxalate crystal-induced renal injury and crystal deposition via regulation of the AR/NOX2 signaling pathway.
    Yuan P; Sun X; Liu X; Hutterer G; Pummer K; Hager B; Ye Z; Chen Z
    Phytomedicine; 2021 Jun; 86():153555. PubMed ID: 33852977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LINC01197 inhibited the formation of calcium oxalate-induced kidney stones by regulating miR-516b-5p/SIRT3/FOXO1 signaling pathway.
    Xi J; Chen Y; Jing J; Qi W; Zhang Y
    Cell Tissue Res; 2023 May; 392(2):553-563. PubMed ID: 36688989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitexin exerts protective effects against calcium oxalate crystal-induced kidney pyroptosis in vivo and in vitro.
    Ding T; Zhao T; Li Y; Liu Z; Ding J; Ji B; Wang Y; Guo Z
    Phytomedicine; 2021 Jun; 86():153562. PubMed ID: 33857849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Protective Roles of Estrogen Receptor
    Zhu W; Zhao Z; Chou FJ; Zuo L; Liu T; Bushinsky D; Chang C; Zeng G; Yeh S
    Oxid Med Cell Longev; 2019; 2019():5305014. PubMed ID: 31178964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization.
    Yang X; Liu H; Ye T; Duan C; Lv P; Wu X; Liu J; Jiang K; Lu H; Yang H; Xia D; Peng E; Chen Z; Tang K; Ye Z
    Theranostics; 2020; 10(26):12011-12025. PubMed ID: 33204326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.